Gamida Cell (GMDA) News Today → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free GMDA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 23, 2024 | bizjournals.comGamida Cell files for U.S. bankruptcy as it undergoes restructuringMarch 28, 2024 | finance.yahoo.comQ4 2023 Gamida Cell Ltd Earnings CallMarch 27, 2024 | finanznachrichten.deGamida Cell, Ltd: Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital ManagementMarch 27, 2024 | finanznachrichten.deGamida Cell, Ltd: Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company UpdateMarch 27, 2024 | msn.comWhy Gamida Cell Shares Are Falling TodayMarch 27, 2024 | investorplace.comGMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023March 27, 2024 | investorplace.comWhy Is Gamida Cell (GMDA) Stock Down 82% Today?March 27, 2024 | msn.comGamida Cell GAAP EPS of $0.57 beats by $0.72, revenue of $1.78M beats by $0.72MMarch 27, 2024 | markets.businessinsider.comGamida Cell Annual Net Loss Narrows; To Be Taken PrivateMarch 27, 2024 | msn.comGamida Cell starts restructuring process supported by Highbridge Capital, stock downMarch 27, 2024 | globenewswire.comGamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company UpdateMarch 27, 2024 | globenewswire.comGamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital ManagementMarch 27, 2024 | benzinga.comGamida Cell Earnings PreviewMarch 22, 2024 | globenewswire.comGamida Cell to Report Fourth Quarter and Full-Year 2023 Financial ResultsMarch 4, 2024 | investing.comGamida Cell (GMDA) Earnings Dates & ReportsFebruary 24, 2024 | msn.comGamida Cell (GMDA) Price Target Increased by 8.33% to 4.42February 23, 2024 | globenewswire.comGamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®February 22, 2024 | benzinga.comGamida Cell Stock (NASDAQ:GMDA), Short Interest ReportFebruary 21, 2024 | finance.yahoo.comGamida Cell Ltd. (GMDA)January 30, 2024 | investing.comGamida Cell Ltd (GMDA)January 29, 2024 | realmoney.thestreet.comGamida Cell just downgraded at JMP Securities, here's whyJanuary 29, 2024 | finanznachrichten.deGamida Cell, Ltd: Gamida Cell Actively Pursuing Strategic AlternativesJanuary 29, 2024 | marketwatch.comGamida Cell Pursues Strategic Options Including Asset Sale, MergerJanuary 29, 2024 | markets.businessinsider.comGamida Cell Actively Pursuing Strategic Alternatives - Quick FactsJanuary 29, 2024 | finance.yahoo.comGamida Cell Actively Pursuing Strategic AlternativesJanuary 17, 2024 | finance.yahoo.comGamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®January 9, 2024 | morningstar.comGamida Cell Ltd GMDADecember 24, 2023 | ca.finance.yahoo.comGMDA Jan 2024 1.000 putDecember 6, 2023 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Gamida Cell (GMDA)December 5, 2023 | markets.businessinsider.comBuy Rating Affirmed for Gamida Cell Amid Omisirge’s Market PotentialNovember 28, 2023 | finance.yahoo.comGamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023November 20, 2023 | finance.yahoo.comGamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare ConferenceNovember 16, 2023 | markets.businessinsider.comVernon Bernardino Recommends ‘Buy’ for Gamida Cell: Promising Growth Trajectory and Expanding Market Access underpin the RatingNovember 15, 2023 | finance.yahoo.comGamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comQ3 2023 Gamida Cell Ltd Earnings CallNovember 15, 2023 | markets.businessinsider.comBuy Rating Justified: Gamida Cell’s Progress and Strategic Moves Despite Capital ConstraintsNovember 14, 2023 | msn.comGamida Cell falls after Q3 revenue missNovember 14, 2023 | finanznachrichten.deGamida Cell, Ltd: Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNovember 14, 2023 | benzinga.comRecap: Gamida Cell Q3 EarningsNovember 14, 2023 | finance.yahoo.comGamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNovember 4, 2023 | finance.yahoo.comGamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 1, 2023 | finance.yahoo.comGamida Cell to Report Third Quarter 2023 Financial ResultsOctober 17, 2023 | msn.comGamida Cell's Blood Cancer Candidate Shows Encouraging Anti-Tumor Activity In Heavily Pretreated PatientsOctober 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA) and Ocular Therapeutix (OCUL)October 16, 2023 | finance.yahoo.comGamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201October 9, 2023 | finance.yahoo.comGamida Cell Issues Update on Israel OperationsOctober 2, 2023 | finance.yahoo.comGamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the MesaSeptember 29, 2023 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Gamida Cell StockSeptember 28, 2023 | msn.comJMP Securities Reiterates Gamida Cell (GMDA) Market Outperform RecommendationSeptember 28, 2023 | finance.yahoo.comGamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting Get Gamida Cell News Delivered to You Automatically Sign up to receive the latest news and ratings for GMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 GMDA Media Mentions By Week GMDA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMDA News Sentiment▼0.000.56▲Average Medical News Sentiment GMDA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMDA Articles This Week▼01▲GMDA Articles Average Week Get Gamida Cell News Delivered to You Automatically Sign up to receive the latest news and ratings for GMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fresh Tracks Therapeutics News TRACON Pharmaceuticals News Titan Pharmaceuticals News Creative Medical Technology News Finch Therapeutics Group News Kiromic BioPharma News Palisade Bio News Avalon GloboCare News Eloxx Pharmaceuticals News Windtree Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GMDA) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gamida Cell Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
